Silva Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 200.2 million compared to BDT 204.05 million a year ago. Net income was BDT 8.38 million compared to BDT 30.1 million a year ago. Basic earnings per share from continuing operations was BDT 0.06 compared to BDT 0.22 a year ago.
For the nine months, sales was BDT 582.5 million compared to BDT 615.86 million a year ago. Net income was BDT 53.39 million compared to BDT 98.99 million a year ago. Basic earnings per share from continuing operations was BDT 0.39 compared to BDT 0.73 a year ago.